Analytical Data
-
基因名
Semaphorin-4D/SEMA4D
- Application
-
种属
Mouse
-
表达系统
HEK293
-
标签
C- mFc
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
O09126
-
表达区间
24-733aa
-
分子量
108.1
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Semaphorin-4D (SEMA4D), a member of the semaphorin family, plays a critical role in various physiological and pathological processes, including immune response, neuronal development, and tumor progression. It functions primarily through its interaction with neuropilin and plexin receptors, influencing cell migration, proliferation, and apoptosis. Research has increasingly focused on the role of SEMA4D in cancer biology, where it has been shown to promote tumor growth, metastasis, and immune evasion by modulating the tumor microenvironment and inhibiting anti-tumor immunity. The overexpression of SEMA4D in several malignancies, such as breast cancer and melanoma, highlights its potential as a therapeutic target. Given its involvement in essential signaling pathways, recombinant SEMA4D proteins have become valuable tools for studying these mechanisms. Moreover, understanding the biological effects of SEMA4D through recombinant proteins can lead to novel therapeutic strategies, including blocking SEMA4D's interactions to enhance anti-tumor immunity and inhibit cancer progression. These insights could pave the way for innovative treatments, particularly in combination with existing immunotherapies. As research continues to elucidate the complex roles of SEMA4D, it remains a promising candidate for targeted therapies aimed at manipulating immune responses and improving clinical outcomes in cancer patients.
